
Loading, please wait...

Loading, please wait...

This randomised controlled trial compared higher-protein with medium-protein delivery in critically ill adults while keeping total energy delivery similar. The study addressed a growing area of interest in critical-care nutrition: whether protein dose, independent of calories, influences recovery and functional outcomes. Patients were assigned to a higher-protein target of approximately 1.8 g/kg/day or a medium-protein target of about 0.9 g/kg/day. The study also considered the interaction between nutrition and early rehabilitation. The findings are best interpreted as part of an evolving evidence base rather than proof that every critically ill patient should receive a high protein dose immediately. Timing, disease phase, organ function, renal replacement, tolerance and mobilisation all affect how protein is handled. This directly aligns with CritiCARE's dedicated nutrition and metabolism sessions on protein delivery, sarcopenia and early rehabilitation. For HCPs, the practical lesson is that protein prescription should be deliberate and monitored rather than driven by a single universal target. The study also highlights a crucial concept in modern ICU care: nutrition and mobilisation should be considered together. Prescribing protein without a plan for recovery and functional rehabilitation may not capture the full clinical objective.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This randomised controlled trial compared higher-protein with medium-protein delivery in critically ill adults while keeping total energy delivery similar. The study addressed a growing area of interest in critical-care nutrition: whether protein dose, independent of calories, influences recovery and functional outcomes. Patients were assigned to a higher-protein target of approximately 1.8 g/kg/day or a medium-protein target of about 0.9 g/kg/day. The study also considered the interaction between nutrition and early rehabilitation. The findings are best interpreted as part of an evolving evidence base rather than proof that every critically ill patient should receive a high protein dose immediately. Timing, disease phase, organ function, renal replacement, tolerance and mobilisation all affect how protein is handled. This directly aligns with CritiCARE's dedicated nutrition and metabolism sessions on protein delivery, sarcopenia and early rehabilitation. For HCPs, the practical lesson is that protein prescription should be deliberate and monitored rather than driven by a single universal target. The study also highlights a crucial concept in modern ICU care: nutrition and mobilisation should be considered together. Prescribing protein without a plan for recovery and functional rehabilitation may not capture the full clinical objective.
last month

Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back

An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
3 days back

Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
3 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week